Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat-Reference-Cited by-同舟云学术

Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat

Published:2022-08 Issue: Volume:929 Page:175090
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Frouni Imane^ORCID,Kang Woojin,Bédard Dominique,Belliveau Sébastien,Kwan Cynthia,Hadj-Youssef Shadi,Bourgeois-Cayer Élodie,Ohlund Leanne,Sleno Lekha,Hamadjida Adjia,Huot Philippe

Publisher

Elsevier BV

Subject

Pharmacology

Reference47 articles.

1. Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov. Disord.,2001

2. Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia;Alberati;Neuropharmacology,2012

3. The concise guide to pharmacology 2017/18: Transporters;Alexander;Br. J. Pharmacol.,2017

4. Alx 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter;Atkinson;Mol. Pharmacol.,2001

5. Tissue concentrations of clozapine and its metabolites in the rat;Baldessarini;Neuropsychopharmacology,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico evidence of bitopertin’s broad interactions within the SLC6 transporter family;Journal of Pharmacy and Pharmacology;2024-07-09

2. Co-agonist glycine controls the occurrence of bursts by activating extrasynaptic NMDARs in nigral dopamine neurons;2024-06-06

3. Glycine and clozapine: potential relevance for the treatment of Parkinson's disease;Neurodegenerative Disease Management;2024-05-09

4. [3H]-NFPS binding to the glycine transporter 1 in the hemi-parkinsonian rat brain;Experimental Brain Research;2024-03-25

5. Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease;Neurobiology of Disease;2024-03